Article: Canaccord Adams hires Dave Schechner as Managing Director; continues building global Life Sciences practice.

BOSTON, May 6 /PRNewswire/ -- Canaccord Adams today announced the continued expansion of its Life Sciences practice, adding senior investment banker, Dave Schechner to its global team. Dave Schechner joins Canaccord Adams as a Managing Director focused on Emerging Therapeutics and will be based in the firm's Boston office. Dave will also be focused on expanding the firm's global Life Sciences mergers and acquisitions business. Over the past year, Canaccord Adams has significantly expanded its global Life Sciences practice and has established significant resources in the US, Canada, and the UK.

"We are very pleased to add Dave's talent and experience to our ...






Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!